Independent GCP audits to verify clinical trial integrity, protect patient safety, and ensure data reliability, in full compliance with FDA, ICH E6(R2), and global regulatory standards.
Clinical research operates in one of the most heavily scrutinized regulatory environments in life sciences. GxP Global Quality Network's GCP auditing services provide sponsors, CROs, and academic research organizations with the independent oversight needed to ensure trial integrity, data reliability, and patient protection.
Our GCP audits are conducted in accordance with ICH E6(R2) Good Clinical Practice guidelines, FDA regulations (21 CFR Parts 50, 54, 56, 312), and applicable EU Clinical Trials Regulation, providing you with defensible, comprehensive audit findings.
All GCP audit reports include: site-specific findings with risk classification, regulatory citation references, sponsor/CRO recommendations, and a CAPA response template to facilitate timely corrective actions and regulatory response preparation.
Quality standard: All GxP Global Quality Network engagements are led by senior-credentialed auditors with 20+ years of active GxP audit experience, regulatory currency across FDA, EMA, MHRA, and Health Canada standards, and direct accountability for every deliverable.